Please login to the form below

benzhydrocodone

This page shows the latest benzhydrocodone news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Director: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Director, Healthcare Marketing Agency: Salary TBC

Account Manager / Account Director: Competative

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Medical Writer: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Senior Account Director development role to Business Director, H...: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Business Director: Competitive Salary Offered

Senior Account Manager: Competitive Salary Offered

Associate Director: £75, 000-90, 000

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director, Medical Education: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....